Navigation Links
DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
Date:8/19/2007

h postoperative VCUG. All patients were kept on prophylactic antibiotics for three months after DEFLUX injection.

After treatment with DEFLUX, 13 percent of patients (n=13) had recurrent UTIs compared to 75 percent (n=75) before DEFLUX treatment, with a five-fold reduction in the incidence of UTIs per year (0.12 +/- 0.04 (p=0.001) post- treatment versus 0.68 +/- 0.09 pre-treatment). DEFLUX also eliminated the need for prophylactic antibiotics in 87 percent of patients. Of the 13 patients with recurrent UTIs after DEFLUX treatment, eight experienced them when they were no longer taking antibiotics. The overall success rate by ureter of DEFLUX treatment in resolving VUR was 77.4 percent after the first injection and 83.9 percent after a second injection. There were no major intraoperative or postoperative complications.

Additional Study Supports Data

A long-term observational study of 179 children with VUR, published in the November 2006 issue of the Journal of Pediatric Urology, showed that in children successfully treated with DEFLUX 74.9 percent of patients experienced no UTIs in the seven-to-12-year follow-up period after DEFLUX treatment (all experienced at least one UTI before treatment). Additionally, 96.6 percent experienced no febrile UTIs (UTIs accompanied by fever) in the follow-period. Most of the post-treatment UTIs reported occurred more than one year after treatment (82.2 percent). Study participants, treated with DEFLUX between 1993 and 1998, were asked to complete a 21-item questionnaire, with parental assistance if required.

DEFLUX, injected endoscopically where the ureter joins the bladder, is typically administered under general anesthesia as an outpatient procedure. The procedure is quick to perform (approximately 15 minutes) and no incision is required. The majority of VUR patients in the U.S. are managed with either antibiotics or an invasive surgical procedure that, while highly effective, requires hospitalization and ca
'/>"/>

SOURCE Q-Med

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
2. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
3. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
6. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
7. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
8. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
9. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
10. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
11. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 ... Market Research "Orthopedic Trauma Fixation Devices Market - Global ... - 2020", the global orthopedic trauma fixation devices market ... is expected to grow at a CAGR of 7.2% ... of USD 9.3 billion in 2020. Browse ...
(Date:7/29/2014)... LAKE CITY and ... -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an ... in the development of improved novel formulations ... active molecules announces expansion of its pharmaceutical ... new development direction includes large molecule drugs that ...
(Date:7/29/2014)... Calif. , July 29, 2014  Based ... response systems (PERS) market, Frost & Sullivan recognizes ... Sullivan Award for Price Performance Value Leadership. MobileHelp,s ... directly captures expectations for tech progression in personal ... consumers for these solutions. MobileHelp is ...
Breaking Medicine Technology:Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 2Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 3
... IRVINE, Calif., and BURLINGTON, Mass., July 18, 2011 ... marketer of minimally invasive treatments for aortic disorders, and ... of peripheral vascular devices and implants, announced today that ... for LeMaitre,s distribution rights of Endologix,s aortic endovascular products ...
... Pa., July 18, 2011 Wolters Kluwer Pharma Solutions, ... pharmaceutical and healthcare professionals, today announced strong impact ... drug therapy and patient management journals.  11 of ... their performance in 2010 a ccording to the annual ...
Cached Medicine Technology:Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products 2Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products 3Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products 4Adis Journals Make Impressive Impact Factor Gains 2Adis Journals Make Impressive Impact Factor Gains 3
(Date:7/29/2014)... NJ (PRWEB) July 29, 2014 Helping ... is an immensely complex challenge that requires deep knowledge ... knowledge to improve therapeutic options and outcomes has been ... professor of biomedical engineering, since he joined the NJIT ... whose significance is underscored by substantial funding from sources ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 A new ... during the 2014 Society for Cardiovascular Angiography and Interventions ... released this week. The videos review the benefits of ... services for the cardiac catheterization laboratory from the perspective ... the first video, Jane Kiah, MS, RN, Director of ...
(Date:7/29/2014)... TUESDAY, July 29, 2014 (HealthDay News) -- Quitting smoking is ... review. Depression can make it more difficult to ... come with trying to quit cold turkey, scientists found. But ... people quit faster, they said. "The review should be ... Moullec, a postdoctoral researcher in the department of exercise science ...
(Date:7/29/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... J. Bowers, PhD, RN, FAAN, of the University of ... on Minority Issues in Gerontology Outstanding Mentorship Award. , ... who has exemplified outstanding commitment and dedication to mentoring ... award presentation will take place at GSA,s 67th Annual ...
(Date:7/29/2014)... drinkers are three times more likely to drink alcohol ... to other alcohol brands, providing new and compelling evidence ... drinking behavior. , This is the conclusion ... Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg ... of Public Health that examined whether exposure to brand-specific ...
Breaking Medicine News(10 mins):Health News:Continuing the Quest for Better Stroke Therapies 2Health News:Continuing the Quest for Better Stroke Therapies 3Health News:Continuing the Quest for Better Stroke Therapies 4Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 3Health News: Extra Exercise Could Help Depressed Smokers Quit: Study 2Health News:Bowers to receive GSA's 2014 Minority Mentorship Award 2Health News:Brand-specific television alcohol ads predict brand consumption among underage youth 2
... 12, 2008 ... , WHO/ WHAT: "Iron Andy" Holder, an Ironman Arizona competitor who was ... this Sunday,s triathlon to encourage others who have chronic ... their condition and to live without limits., ...
... Up to Promote New Appliance Line,s European, Style and Ingenious Features ... ... YORK, April 3, 2008 Known and admired for her,multi-tasking talents as ... Ripa for the North America launch of its new,premium kitchen appliance line ...
... screening, recommended by the Centers for Disease Control, ... critical to preventing still births and serious birth ... study published in the April issue of the ... statistics, when used to determine screening rates, may ...
... gap between stated and unstated feelings about Clinton, ... people feel more "insecure" than they are typically willing,to ... Company. In,addition, the "confidence" voters express about the U.S. ... surface and therefore does not appear to be,very deep., ...
... April 3, 2008 /PRNewswire/ - The GLOBAL ... service for,business executives in pharmaceutical and life ... and other industries,launches a Virtual Tour of ... COUNCIL service by visiting, http://www3.best-in-class.com/gr148.htm or ...
... The International Neuroinformatics Coordinating Facility (INCF) announces further ... the Neuroscience Peer Review Consortium (NPRC) initiative. The ... have agreed to accept manuscript reviews from other ... research articles. Currently, 27 journals have joined the ...
Cached Medicine News:Health News:Ironman Competitor with Diabetes Encourages Others to Live Without Limits; Competes in Ironman Arizona in Tempe 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 3Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 4Health News:Prenatal syphilis screening rates: Are they being accurately reported? 2Health News:Voting for Clinton Evokes Deep-Seated Feelings of Insecurity 2Health News:Global Benchmarking Council Launches New Virtual Tour of Research & Networking Service 2Health News:Neuroscience Peer Review Consortium announces increased journal participation 2
... range of procedure-specific designs for all surgical ... the world. Surgical needs such as strength, ... using different materials to provide performance where ... in a wide array of formats, including ...
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification...
The Model 273 is a general purpose instrument with output that may be either DC-coupled for very slow changes such as venous occlusion and penile tumescence studies or AC-coupled for respiratory or p...
... NEVA™ System is designed to ... within the penis nocturnally. Three ... monitor and record impedance data ... in penile blood volume. The ...
Medicine Products: